Edition:
United Kingdom

Vertex Pharmaceuticals Inc (VRTX.OQ)

VRTX.OQ on NASDAQ Stock Exchange Global Select Market

173.23USD
11 Dec 2018
Change (% chg)

$-0.55 (-0.32%)
Prev Close
$173.78
Open
$176.29
Day's High
$176.29
Day's Low
$170.92
Volume
382,605
Avg. Vol
486,550
52-wk High
$194.85
52-wk Low
$139.80

Select another date:

Tue, Nov 27 2018

Vertex posts positive data from cystic fibrosis triple combo trials

Vertex Pharmaceuticals Inc said on Tuesday that its triple combination therapy showed significant improvement in lung function in patients with cystic fibrosis (CF) in two late-stage clinical studies, sending its shares up 5 percent.

REFILE-Vertex posts positive data from cystic fibrosis triple combo trials

Nov 27 Vertex Pharmaceuticals Inc said on Tuesday that its triple combination therapy showed significant improvement in lung function in patients with cystic fibrosis (CF) in two late-stage clinical studies, sending its shares up 5 percent.

Vertex cystic fibrosis drug gets expanded approval for use in infants

U.S. health regulators have expanded the use of one of Vertex Pharmaceuticals Inc's cystic fibrosis drugs to include patients aged between 12 months and 24 months.

Vertex cystic fibrosis drug gets expanded approval for use in infants

Aug 15 U.S. health regulators have expanded the use of one of Vertex Pharmaceuticals Inc's cystic fibrosis drugs to include patients aged between 12 months and 24 months.

Select another date: